Summary:
A 40-week research study is evaluating a NEW investigational insulin treatment that may provide better blood sugar control in people with type 2 diabetes.
Qualified Participants Must:
• Be 18 years of age or older
•
Have type 2 diabetes
•
Be treated with long acting insulin
•
Be treated with the oral anti-diabetic drug metformin
•
Have a BMI < 40 kg/m2
Qualified Participants May Receive:
Study related care and study medication at no cost and may be compensated for travel.